MANUAL, founded in 2018 and headquartered in the United Kingdom, is a pioneering digital healthcare provider committed to "Building more good years into life." The company takes a comprehensive approach to healthcare delivery, focusing specifically on life-impeding conditions such as hormonal imbalance, obesity, and hair loss.
With its innovative model, MANUAL seamlessly integrates diagnosis, custom medications, specialist services, and treatment management. This model has attracted over 500k patients across UK and Brazil, showcasing robust user adoption and geographical diversification. The company prides itself on enhancing patient outcomes, with over 90% of patients experiencing an improved Quality of Life within six months.
Financially, MANUAL has demonstrated strong growth, securing $30m in funding from leading investors. Most recently, it received a Venture Round investment on 11 April 2024, led by FJ Labs. This positions MANUAL favorably for scaling its impact and expanding its services beyond its current markets.